当前位置:首页 - 行情中心 - 新华制药(000756) - 财务分析 - 现金流量表

新华制药

(000756)

  

流通市值:73.14亿  总市值:102.13亿
流通股本:4.99亿   总股本:6.97亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,873,080,879.597,821,587,287.235,759,173,328.33,806,443,339.79
  收到的税费返还18,065,843.3262,621,737.0957,238,889.5134,313,637.83
  收到其他与经营活动有关的现金25,175,301.4947,618,648.1441,299,954.136,470,462.71
  经营活动现金流入小计1,916,322,024.47,931,827,672.465,857,712,171.913,877,227,440.33
  购买商品、接受劳务支付的现金1,565,015,221.765,634,520,638.324,252,434,435.682,782,539,243.67
  支付给职工以及为职工支付的现金244,464,892.121,006,072,823.4763,390,417.43534,879,287.39
  支付的各项税费84,246,612.02205,120,205.35170,288,449.73105,157,989.92
  支付其他与经营活动有关的现金139,148,001.59552,385,297.65349,600,006.1220,518,566.62
  经营活动现金流出小计2,032,874,727.497,398,098,964.725,535,713,308.943,643,095,087.6
  经营活动产生的现金流量净额-116,552,703.09533,728,707.74321,998,862.97234,132,352.73
二、投资活动产生的现金流量:
  取得投资收益收到的现金-9,799,737.768,515,076.83,115,076.8
  处置固定资产、无形资产和其他长期资产收回的现金净额735,300768,995.95735,731.49439,943.89
  收到的其他与投资活动有关的现金109,4001,529,792.061,473,78013,440
  投资活动现金流入小计844,70012,098,525.7710,724,588.293,568,460.69
  购建固定资产、无形资产和其他长期资产支付的现金27,430,037.86115,602,127.29103,668,229.9376,807,920.68
  支付其他与投资活动有关的现金--3,000,0003,000,000
  投资活动现金流出小计27,430,037.86115,602,127.29106,668,229.9379,807,920.68
  投资活动产生的现金流量净额-26,585,337.86-103,503,601.52-95,943,641.64-76,239,459.99
三、筹资活动产生的现金流量:
  吸收投资收到的现金48,340,450.556,172,46155,577,524.555,577,524.5
  其中:子公司吸收少数股东投资收到的现金-3,000,000--
  取得借款收到的现金280,000,000979,800,000749,800,000459,800,000
  收到其他与筹资活动有关的现金33,000,0005,260,0005,260,0002,000,000
  筹资活动现金流入小计361,340,450.51,041,232,461810,637,524.5517,377,524.5
  偿还债务支付的现金342,000,0001,111,677,569.79842,677,569.79622,977,569.79
  分配股利、利润或偿付利息支付的现金6,895,211.3218,762,051.81210,599,035.0330,301,466.88
  其中:子公司支付给少数股东的股利、利润-8,982,0008,982,0008,982,000
  支付其他与筹资活动有关的现金642,587.551,921,057.421,477,894.87814,747.45
  筹资活动现金流出小计349,537,798.851,332,360,679.021,054,754,499.69654,093,784.12
  筹资活动产生的现金流量净额11,802,651.65-291,128,218.02-244,116,975.19-136,716,259.62
四、汇率变动对现金及现金等价物的影响2,343,164.687,237,015.536,124,226.965,778,620.84
五、现金及现金等价物净增加额-128,992,224.62146,333,903.73-11,937,526.926,955,253.96
  加:期初现金及现金等价物余额1,283,208,913.791,136,875,010.061,136,875,010.061,136,875,010.06
  期末现金及现金等价物余额1,154,216,689.171,283,208,913.791,124,937,483.161,163,830,264.02
补充资料:
  净利润-306,303,918.15-231,168,471.79
  资产减值准备-47,394,139.35-50,287,533.79
  固定资产和投资性房地产折旧-512,529,806.51-250,047,274.54
  无形资产摊销-73,577,903.29-31,067,568.57
  长期待摊费用摊销-4,347,764.33-2,348,380.85
  处置固定资产、无形资产和其他长期资产的损失--1,990,589.09--1,711,209.17
  固定资产报废损失-1,043,407.59-236,486.07
  财务费用-35,194,311.86-15,670,470.77
  投资损失--7,764,521.27--5,879,082.58
  递延所得税--315,974.22-5,365,550.9
  其中:递延所得税资产减少-3,730,000.74-6,856,749.64
    递延所得税负债增加--4,045,974.96--1,491,198.74
  存货的减少--92,833,245.57--6,560,276.59
  经营性应收项目的减少--547,754,132.8--427,595,333.26
  经营性应付项目的增加-184,716,546.76-72,201,697.84
  其他-12,517,620.5-7,568,060.46
  现金的期末余额-1,283,208,913.79-1,163,830,264.02
  减:现金的期初余额-1,136,875,010.06-1,136,875,010.06
  现金及现金等价物的净增加额-146,333,903.73-26,955,253.96
公告日期2026-04-292026-03-302025-10-252025-08-27
审计意见(境内)标准无保留意见
TOP↑